Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations

SIMPLE SUMMARY: The oligoprogression concept is characterized by a limited number and/or sites of metastases in which a disease progression appears, and a more indolent tumor biology, raised specifically for oncogene addicted non-small cell lung cancer (NSCLC), including the epidermal growth factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossi, Antonio, Galetta, Domenico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834352/
https://www.ncbi.nlm.nih.gov/pubmed/35159099
http://dx.doi.org/10.3390/cancers14030832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834352/
https://www.ncbi.nlm.nih.gov/pubmed/35159099
http://dx.doi.org/10.3390/cancers14030832

Ejemplares similares